Who owns Ovid Therapeutics Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of OVID from SEC Form 13F filings across 129 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 129 institutions disclosed 148.4M shares of Ovid Therapeutics Inc. worth $369.4M — about 201.3% of shares outstanding; the largest disclosed holder is Janus Henderson Group Ltd.. Source: SEC Form 13F filings, parsed by EvidInvest.
129
13F holders
$369.4M
value, 2026 filers
201.3%
of shares outstanding (148.4M sh)
15
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of OVID's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Janus Henderson Group Ltd.NEW | 20.7M | $51.5M | 0.0% | 28.1% | new |
| 2 | BlackRock, Inc. | 12.1M | $30.0M | 0.0% | 16.3% | +11.3% |
| 3 | EVENTIDE ASSET MANAGEMENT, LLC | 11.8M | $29.4M | 0.4% | 16% | 0.0% |
| 4 | Affinity Asset Advisors, LLC | 10.1M | $25.3M | 1.0% | 13.8% | 0.0% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 7.8M | $19.5M | 0.0% | 10.6% | +0.9% |
| 6 | Balyasny Asset Management L.P. | 7.1M | $17.7M | 0.0% | 9.7% | +5.9% |
| 7 | BRAIDWELL LP | 6.6M | $16.4M | 0.7% | 8.9% | +11.2% |
| 8 | STATE STREET CORP | 6.2M | $15.4M | 0.0% | 8.4% | -21.5% |
| 9 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 6.2M | $15.3M | 0.0% | 8.4% | 0.0% |
| 10 | FEDERATED HERMES, INC. | 6.0M | $14.8M | 0.0% | 8.1% | 0.0% |
| 11 | SILVERARC CAPITAL MANAGEMENT, LLC | 6.0M | $14.8M | 1.7% | 8.1% | +91.9% |
| 12 | RA CAPITAL MANAGEMENT, L.P. | 5.6M | $13.9M | 0.1% | 7.6% | -46.7% |
| 13 | ADAR1 Capital Management, LLC | 4.6M | $11.4M | 0.5% | 6.2% | -38.5% |
| 14 | GEODE CAPITAL MANAGEMENT, LLC | 4.3M | $10.7M | 0.0% | 5.8% | +5.6% |
| 15 | Integral Health Asset Management, LLCNEW | 3.5M | $8.7M | 0.5% | 4.7% | new |
| 16 | Point72 Asset Management, L.P. | 2.5M | $6.3M | 0.0% | 3.5% | +31.0% |
| 17 | Ikarian Capital, LLC | 2.1M | $5.3M | 0.5% | 2.9% | -6.6% |
| 18 | VANGUARD PORTFOLIO MANAGEMENT LLC | 1.7M | $4.2M | 0.0% | 2.3% | +61.7% |
| 19 | SPHERA FUNDS MANAGEMENT LTD. | 1.6M | $4.0M | 0.6% | 2.2% | +18.3% |
| 20 | NORTHERN TRUST CORP | 1.3M | $3.2M | 0.0% | 1.8% | +4.6% |
| 21 | STEMPOINT CAPITAL LP | 1.3M | $3.2M | 0.6% | 1.7% | -46.7% |
| 22 | VANGUARD FIDUCIARY TRUST CO | 1.2M | $3.0M | 0.0% | 1.6% | +4.8% |
| 23 | Rosalind Advisors, Inc. | 1.1M | $2.8M | 0.9% | 1.5% | 0.0% |
| 24 | Propel Bio Management, LLC | 1.0M | $2.5M | 1.3% | 1.4% | -8.7% |
| 25 | Atom Investors LP | 1.0M | $2.5M | 0.1% | 1.4% | +303.8% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.